Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: A 12-month follow-up

Digestive Diseases and Sciences

Volumn 52, Issue 11, 2007, Pages 2934-2941

  Comparato, Giuseppe ^a   Fanigliulo, Libera ^a   Cavallaro, Lucas G ^a   Aragona, Giovanni ^b   Cavestro, Giulia Martina ^a   Iori, Veronica ^a   Maino, Marta ^a   Mazzocchi, Giancarlo ^c   Muzzetto, Pierantonio ^d   Colla, Giancarlo ^d   Sianesi, Mario ^a   Franzé, Angelo ^d   Mario, Francesco Di ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b Az Ospedaliera   (Italy)

^c AUSL   (Italy)

^d Az Ospedaliera   (Italy)

Author keywords

Diverticula; Diverticular disease; Mesalazine

Indexed keywords

MESALAZINE; RIFAXIMIN;

ADULT; AGED; ARTICLE; ASTHENIA; CONTROLLED STUDY; DIVERTICULOSIS; FEMALE; FOLLOW UP; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PARAMETER; PRIORITY JOURNAL; RECURRENT DISEASE; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BARIUM SULFATE; COLONOSCOPY; CONTRAST MEDIA; DIVERTICULITIS, COLONIC; DIVERTICULOSIS, COLONIC; ENEMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MESALAMINE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOGRAPHY, ABDOMINAL; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 34848886591     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-9766-8     Document Type: Article

References (33)

1. Stollman NH, Baskin JB, for and on behalf of the Ad Hoc Practice Parameters Committee of the American College of Gastroenterology (1999) Diagnosis and management of diverticular disease of the colon in adults. Practice guidelines. Am J Gastroenterol 94(11):3110-3121
2. Salzman H, Dustin L (2005) Diverticular disease: diagnosis and treatment. Am Fam Phys 72(7):1230-1234
3. Almy TP, Howell DA (1980) Diverticular disease of the colon. N Engl J Med 302:324-331
4. Kohler L, Sauerland S, Neugebauer E, for the Scientific Committee of the European Association for Endoscopic Surgery (1999) Diagnosis and treatment of diverticular disease. Results of a consensus development conference. Surg Endosc 13:430-436
5. Schwartz JT, Graham DY (1998) Diverticular disease of the large intestine. In: Diseases of the colon, rectum and anal canal. Kirsner J, Shorter R (eds). Williams & Wilkins, Baltimore, pp 519-536
6. Naitove A, Smith RE (1993) Diverticular disease of the colon. In: Gastrointestinal disease, 5th ed. Sleisenger MH, Fordtran TS (eds). Saunders, Philadelphia, pp 1347-1363
7. Aldoori WH, Giovannucci EL, Rockett HR, et al. (1998) A prospective study of dietary fiber types and symptomatic diverticular disease in men. J Nutr 128:714-719
8. Brodribb AJ (1977) Treatment of symptomatic diverticular disease with a high-fibre diet. Lancet 1(8013):664-666
9. Ewerth S, Ahlberg J, Holmstrom B, Persson U, Uden R (1980) Influence on symptoms and transit time of Vi SiblinR in diverticular disease. Acta Chir Scand 500:40-59
10. Solotoft J, Gudmand-Hoyer E, Krag B, Kristensen E, Wulff HR (1976) A double blind trial of wheat bran on symptoms of irritable bowel syndrome. Lancet 1(7954):270-272
11. Fric P, Zavoral M (2003) The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon. Eur J Gastroenterol Hepatol 15(3):313-315
12. Papi C, Ciaco A, Koch M, et al. (1995) Efficacy of rifaximine in the treatmentof symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial. Aliment Pharmacol Ther 9:33-39
13. Latella G, Pimpo MT, Sottili S, et al. (2003) Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis 18:55-62
14. Stollman N, Raskin JB (2004) Diverticular disease of the colon. Lancet 363:631-639
15. Bassotti G, Chistolini F, Morelli A (2003) Pathophysiological aspects of diverticular disease of colon and role of large bowel motilità. World J Gastroenterol 9(10):2140-2142
16. Simpson J, Scholefield JH, Spiller RC (2002) Pathogenesis of colonic diverticula. Br J Surgery 89:546-554
17. Bode MK, Karttunen TJ, Makela J, et al. (2000) Type I and III collagens in human colon cancer and diverticulosis. Scand J Gastroenterol 35:747-752
18. Painter NS, Burkitt DP (1975) Diverticular disease of the colon, a 20th century problem. Clin Gastroenterol 4:3-21
19. Ghorai S, Ulbright TM, Douglas K, et al. (2003) Endoscopic findings of diverticular inflammation in colonscopy patients with clinical acute diverticulitis: prevalence and endoscopic spectrum. Am J Gastroenterol 98(4):76-84
20. Makapugay LM, Dean PJ (1996) Diverticular disease-associated chronic colitis. Am J Surg Pathol 20(1):94-102
21. Peppercorn MA (2004) The overlap of inflammatory bowel disease and diverticular disease. J Clin Gastroenterol 38 (Suppl 1):S8-S10
22. Sheperd NA (1996) Diverticular disease and chronic idiopathic inflammatory bowel disease: associations and masquerades. Gut 38:801-802
23. Tursi A (2005) Mesalazine for diverticular disease of the colon-a new role for an old drug. Expert Opin Pharmacother 6(1):69-74
24. Eliakim R, Rachmilewitz D (1992) Potenzial mediators in inflammatory bowel disease. Gastroenterol Int 5:48-56
25. Grisham MB (1994) Oxidants and free radicals in inflammatory bowel disease. Lancet 344:859-861
26. Wood AJJ (1996) Inflammatory bowel disease. N Engl J Med 334:841-848
27. Goncalves E, Almeida LM, Dinis TC (1998) Antioxidant activity of 5-aminosalicylic acid against peroxidation of phosphatidylcholine liposomes in the presence of alpha-tocopherol: A synergistic interaction? Free Rad Res 29:53-66
28. Gore S, Sheperd NA, Wilkinson SP (1992) Endoscopic crescentic fold disease of the sigmoid colon: the clinical and hystopathological spectrum of a distinctive endoscopic appearance. Int J Colorect Dis 7:76-81
29. Tursi A (2004) Diverticular disease of the colon. Lancet 363:1397-1398
30. Peppercorn MA (1992) Drug-responsive chronic segmental colitis associated with diverticula: a clinical syndrome in the elderly. Am J Gastroenterol 87:609-612
31. Trespi E, Colla C, Panizza P, Polino MG, Venturini A, Bottani G, De Vecchi P, Matti C (1999) Ruolo terapeutico e profilattico della mesalazina (5-ASA) nella malattia diverticolare sintomatica del crasso. Minerva Gastroenterol Dietol 45:245-252
32. Tursi A, Brandimarte G, Daffinà R (2002) Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon. Dig Liver Dis 34:510-515
33. Di Mario F, Aragona G, Leandro G, et al. (2005) Efficacy of mesalazine in the treatment of symptomatic diverticular disease. Dig Dis Sci 50:581-586